McErlean, P; Bell, CG; Hewitt, RJ; Busharat, Z; Ogger, PP; Ghai, P; Albers, GJ; ... Byrne, AJ; + view all McErlean, P; Bell, CG; Hewitt, RJ; Busharat, Z; Ogger, PP; Ghai, P; Albers, GJ; Calamita, E; Kingston, S; Molyneaux, PL; Beck, S; Lloyd, CM; Maher, TM; Byrne, AJ; - view fewer (2021) DNA Methylome Alterations are Associated with Airway Macrophage Differentiation and Phenotype During Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine , 204 (8) pp. 954-966. 10.1164/rccm.202101-0004OC.

Preview

Text rccm.202101-0004oc.pdf - Accepted Version Download (3MB) | Preview

Abstract

RATIONALE: Airway macrophages (AMs) are key regulators of the lung environment and are implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a fatal respiratory disease with no cure. However, knowledge of epigenetics of AMs in IPF are limited. METHODS: We undertook DNA methylation profiling using Illumina EPIC (850k) arrays in sorted AMs from Healthy (n=14) and IPF (n=30) donors. Cell-type deconvolution was performed using reference myeloid-cell DNA methylomes. MEASUREMENTS AND MAIN RESULTS: Our analysis revealed epigenetic heterogeneity was a key characteristic of IPF-AMs. DNAm 'clock' analysis indicated epigenetic alterations in IPF-AMs was not associated with accelerated ageing. In differential DNAm analysis, we identified numerous differentially methylated positions (DMPs, n=11) and regions (DMRs, n=49) between healthy and IPF AMs respectively. DMPs and DMRs encompassed genes involved in lipid (LPCAT1) and glucose (PFKFB3) metabolism and importantly, DNAm status was associated with disease severity in IPF. CONCLUSIONS: Collectively, our data identify that changes in the epigenome are associated with development and function of AMs in the IPF lung.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as CSVJSONXML

Downloads by country - last 12 months

Export as CSVJSONXML

Archive Staff Only

View Item